Skinny Labeling Saved Medicare $1.5 Billion over 5 Years, Study Finds

Biosimilars with “skinny labeling” saved Medicare $1.5 billion over 5 years, equivalent to almost 5 percent of what the federal system spent on five pricey biologics, according to a new report in JAMA Network.
Source: Drug Industry Daily